Related Experiment Video
Updated: Jun 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Chronic inflammation in patients with acute coronary syndrome and chronic kidney disease]
Aleksander Owczarek1, Magdalena Babińska, Bożena Szyguła-Jurkiewicz
1Zakład Statystyki, Śląski Uniwersytet Medyczny w Katowicach, Sosnowiec. aowczarek@sum.edu.pl
Insights
Chronic kidney disease (CKD) increases the risk of acute coronary syndrome (ACS) due to cardiovascular complications. Inflammation plays a key role in CKD patients, driving atherosclerosis and plaque instability leading to ACS.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Context:
- Chronic kidney disease (CKD) is a global health concern.
- CKD is a significant risk factor for acute coronary syndrome (ACS).
- Cardiovascular diseases are more prevalent in CKD patients due to diabetes, hypertension, and impaired coagulation.
Purpose:
- To explore the link between chronic kidney disease and cardiovascular complications.
- To highlight the role of inflammation in the pathogenesis of cardiovascular diseases in CKD patients.
- To identify key inflammatory mediators involved in ACS development.
Summary:
- CKD contributes to cardiovascular complications, increasing ACS risk.
- Inflammation, a non-traditional risk factor, drives atherosclerosis and plaque instability in CKD.
- Key inflammatory mediators include C-reactive protein, adhesion molecules, and cytokines.
Impact:
- Understanding the inflammatory pathways in CKD-ACS can lead to targeted therapies.
- This research underscores the importance of managing inflammation in CKD patients to reduce cardiovascular events.
- Improved cardiovascular risk stratification and management strategies for CKD patients.
Abstract:
Chronic kidney disease is a worldwide growing problem in public health. It is a risk factor for complications in patients with acute coronary syndrome (ACS). Diabetes, hypertension (hypertrophy and left ventricular failure), impaired fibrinolysis and coagulation processes, as well as the rapid development of atherosclerosis (partly associated with chronic inflammation) are responsible for higher prevalence of cardiovascular diseases in patients with chronic kidney disease. Inflammatory process of unknown aetiology belongs to the so-called non-traditional risk factors in development of cardiovascular system diseases. It is thought that this process is responsible for adverse remodelling of atherosclerosis plaque and its instability which causes plaque rupture and as a result a coronary syndrome occurrence. Important inflammatory mediators, which take part in pathogenesis of ACS, are acute phase proteins such as: C-reactive protein, adhesion molecules VCAM-1, ICAM-1, selectins, plasma amyloid A, metalloproteinases, interleukins-1 and -6, tumour necrosis factor-a and vascular endothelial growth factor.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction